Loading clinical trials...
Loading clinical trials...
Compare the data obtained with two formulations of alendronate 70 mg (tablets vs effervescent tablet for buffered solution) on the change in bone turnover markers, on gastric tolerance and on treatmen...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Labatec Pharma SA
NCT06558188 · Osteoporosis, Postmenopausal, Osteoporosis
NCT05575167 · Osteoporosis, Postmenopausal
NCT05228262 · Osteoporosis, Postmenopausal
NCT06375668 · Osteoporosis, Postmenopausal, Bone Density, Low
NCT03232476 · Osteoporosis, Postmenopausal
Endokrinologische Praxis & Labor
Basel, Canton of Basel-City
Hôpital Universitaire de Genève, Service des maladies osseuses
Geneva, Canton of Geneva
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions